Meritain Health policies, page 105

Search Meritain Health's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Meritain Health, by title.

Meritain Health policies
PolicyDetailsCodesSource
Skilled Home Private Duty Nursing Care0136 · Commercial58Original policy ↗
Skin and Soft Tissue Substitutes0244 · Commercial525Original policy ↗
Sklice ST, Post PA Policy 3744-D 03-20223744-D · Commercial—Original policy ↗
Skyrizi SGM 3047-A P2026a3047-A P2026a · Commercial—Original policy ↗
Smell and Taste Disorders: Diagnosis0390 · Commercial40Original policy ↗
sodium oxybate-Lumryz-Xyrem SGM 3677-A, 6975-A P20263677-A, 6975-A P2026 · Commercial—Original policy ↗
Soma Limit Policy 206-H 10-2021206-H · Commercial—Original policy ↗
Somatostatin Analogs0693 · Commercial31Original policy ↗
Soriatane PA with Limit 208-C 07-2022208-C · Commercial—Original policy ↗
Sorilux Limit, Post PA Policy 2932-HJ UDR 07-20232932-HJ · Commercial—Original policy ↗
Sorilux Limit, Post PA Policy 2932-HJ UDR 07-20232932-HJ · Commercial—Original policy ↗
Sotyktu 5600-A SGM P20245600-A · Commercial—Original policy ↗
Spasticity Management0362 · Commercial79Original policy ↗
Specialty Quantity Limit abiraterone-Zytiga 1878-H P20221878-H · Commercial—Original policy ↗
Specialty Quantity Limit abiraterone-Zytiga 1878-H P20231878-H · Commercial—Original policy ↗
Specialty Quantity Limit Arcalyst 1744-H P20261744-H P2026 · Commercial—Original policy ↗
Specialty Quantity Limit Ayvakit 3492-H P2021a3492-H P2021a · Commercial—Original policy ↗
Specialty Quantity Limit Balversa 2968-H P20232968-H · Commercial—Original policy ↗
Specialty Quantity Limit Benlysta 3027-H P20263027-H · Commercial—Original policy ↗
Specialty Quantity Limit Bimzelx 6221-H P20236221-H · Commercial—Original policy ↗
Specialty Quantity Limit Bimzelx 6221-H P20236221-H · Commercial—Original policy ↗
Specialty Quantity Limit Bimzelx 6221-H P20266221-H P2026 · Commercial—Original policy ↗
Specialty Quantity Limit Bosulif 1720-H P2023a1720-H P2023a · Commercial—Original policy ↗
Specialty Quantity Limit Buphenyl 3016-H P20223016-H · Commercial—Original policy ↗
Specialty Quantity Limit Calquence 2411-H P20232411-H · Commercial—Original policy ↗
Specialty Quantity Limit Camzyos 5442-H P20255442-H · Commercial—Original policy ↗
Specialty Quantity Limit Cimzia 2267-H P20252267-H · Commercial—Original policy ↗
Specialty Quantity Limit cinacalcet-Sensipar 1625-H P2022a1625-H P2022a · Commercial—Original policy ↗
Specialty Quantity Limit cinacalcet-Sensipar 1625-H P20241625-H · Commercial—Original policy ↗
Specialty Quantity Limit Copiktra 2759-H P20222759-H · Commercial—Original policy ↗
Specialty Quantity Limit Copiktra 2759-H P20232759-H · Commercial—Original policy ↗
Specialty Quantity Limit dasatinib products 1722-H P20251722-H · Commercial—Original policy ↗
Specialty Quantity Limit Daybue 5834-H P20245834-H · Commercial—Original policy ↗
Specialty Quantity Limit dichlorphenamide-Keveyis-Ormalvi 2994-H P20262994-H P2026 · Commercial—Original policy ↗
Specialty Quantity Limit droxidopa-Northera 2263-H P20262263-H P2026 · Commercial—Original policy ↗
Specialty Quantity Limit Empaveli 4741-H P20234741-H · Commercial—Original policy ↗
Specialty Quantity Limit Empaveli 4741-H P20254741-H · Commercial—Original policy ↗
Specialty Quantity Limit Empaveli 4741-H P20254741-H · Commercial—Original policy ↗
Specialty Quantity Limit Endari 2183-H P20232183-H · Commercial—Original policy ↗
Specialty Quantity Limit Endari 2183-H P20232183-H · Commercial—Original policy ↗
Specialty Quantity Limit Endari 2183-H P20232183-H · Commercial—Original policy ↗
Specialty Quantity Limit entecavir-Baraclude 4780-H P20234780-H · Commercial—Original policy ↗
Specialty Quantity Limit Entyvio 2269-H P20262269-H · Commercial—Original policy ↗
Specialty Quantity Limit Epidiolex 2611-H P20232611-H · Commercial—Original policy ↗
Specialty Quantity Limit Erleada 2503-H P2022a2503-H P2022a · Commercial—Original policy ↗
Specialty Quantity Limit erlotinib 1756-H P20241756-H · Commercial—Original policy ↗
Specialty Quantity Limit erlotinib 1756-H P20241756-H · Commercial—Original policy ↗
Specialty Quantity Limit Esbriet 3205-H P20223205-H · Commercial—Original policy ↗
Specialty Quantity Limit everolimus-Afinitor Products 2223-H P20232223-H P2023 · Commercial—Original policy ↗
Specialty Quantity Limit Evrysdi 4084-H P2022a4084-H P2022a · Commercial—Original policy ↗

Back to Meritain Health

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.